Merck & Co Inc at JPMorgan Healthcare Conference Transcript
Good afternoon. I'm Chris Schott at JPMorgan, and it's my pleasure to be wrapping up day 1 of the JPMorgan conference with the presentation from Merck. From the company, we have the company's Chairman and CEO, Rob Davis; as well as Dean Li, who is President of Merck Research Labs. After a very successful 2022 for the company, looking forward to Rob's presentation and comments on '23 and beyond. And then after the presentation, we'll go to some fireside chat Q&A on the stage here.
So with that, I'll turn it over to Rob.
Thanks a lot.
Thanks so much.
Appreciate it. Thank you. Good afternoon, everybody. Obviously, we will be making forward-looking statements, and I'd
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
